Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Advances in Musculoskeletal Tissue Biology and Regenerative Techniques: Innovative Approaches to Bone Repair and Cartilage Regeneration in Orthopedic Surgery

Nakkaragundi MS., Kerketta AH., Jawahar PP., Jain K., Satapathy D., Singh A.

Narrative Review on Osteoarthritis, Cartilage Damage, published in Cureus (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Cureus (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42110057
PMCID
PMC13153734
DOI
10.7759/cureus.106623

Abstract (original English)

Musculoskeletal disorders involving bone and cartilage remain a major clinical burden because these tissues have limited intrinsic regenerative capacity, and conventional orthopedic treatments often fail to restore durable structural and functional outcomes. Advances in musculoskeletal tissue biology have clarified the complex cellular, molecular, immunological, and biomechanical regulators of healing, forming a strong foundation for the development of next-generation regenerative therapies. Emerging strategies, including orthobiologic preparations, stem cell-based interventions, biomimetic and smart biomaterial scaffolds, nanotechnology-driven platforms, and three-dimensional bioprinting, have demonstrated improvements in matrix synthesis, angiogenesis, and inflammatory modulation in preclinical models and early clinical studies, with recent advances also showing improved control of cell differentiation, enhanced scaffold integration, and more precise tissue architecture. Clinical evidence suggests benefits, including enhanced fracture healing, improved repair of cartilage defects, and symptomatic relief in early osteoarthritis. However, outcomes remain variable due to heterogeneity in biologic preparations and study designs. Despite these advances, major challenges persist, including variability in biologic preparations, limited long-term clinical evidence, difficulties achie

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research